Drug Profile
Ethynylthymidine
Latest Information Update: 18 May 2001
Price :
$50
*
At a glance
- Originator Louisiana State University
- Class Antivirals; Nucleosides
- Mechanism of Action Thymidine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 18 May 2001 Profile reviewed but no significant changes made
- 18 May 2001 No-Development-Reported for Herpesvirus infections in USA (Unknown route)